Workflow
CORT's Q1 Earnings In Line With Estimates, Revenues Lag, Shares Fall
CORTcept Therapeutics rporated(CORT) ZACKS·2025-05-07 02:15

Corcept Therapeutics Incorporated (CORT) reported first-quarter 2025 earnings of 17 cents per share, which were in line with the Zacks Consensus Estimate. The company had reported earnings of 25 cents per share in the year-ago quarter.Revenues in the first quarter increased 7.1% year over year to 157.2million.Thefigure,however,missedtheZacksConsensusEstimateof157.2 million. The figure, however, missed the Zacks Consensus Estimate of 178 million. The top line solely comprises product sales of the Cushing’s syndrome drug, Korlym. (Find the latest EPS estimates and surpr ...